Literature DB >> 2992649

Forskolin: its effects on potassium-evoked release of vasopressin from the rat neurohypophysis.

D Bowman, D B Hope.   

Abstract

The effect of forskolin, added either before or 5 min after the onset of potassium-evoked release of vasopressin from isolated neurointermediate lobes of the rat has been investigated. A low concentration of forskolin (1 microM), added before stimulation, enhanced the potassium-evoked release of vasopressin throughout two successive 5 min periods of stimulation. Higher concentrations of forskolin (10-80 microM) produced no effect on the potassium-evoked release of hormone during the first 5 min of stimulation, but inhibited release during the second 5 min period. When added 5 min after the onset of potassium stimulation, forskolin (1-80 microM) reduced the amount of vasopressin released during the remaining 5 min of stimulation. Forskolin produced a concentration-dependent increase in cyclic AMP during both the control and potassium stimulation periods. The amount of cyclic AMP generated by forskolin during potassium stimulation was less than that produced during the corresponding control periods.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2992649      PMCID: PMC1916769          DOI: 10.1111/j.1476-5381.1985.tb08847.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  25 in total

1.  STIMULUS-SECRETION COUPLING IN A NEUROSECRETORY ORGAN: THE ROLE OF CALCIUM IN THE RELEASE OF VASOPRESSIN FROM THE NEUROHYPOPHYSIS.

Authors:  W W DOUGLAS; A M POISNER
Journal:  J Physiol       Date:  1964-07       Impact factor: 5.182

2.  CALCIUM MOVEMENT IN THE NEUROHYPOPHYSIS OF THE RAT AND ITS RELATION TO THE RELEASE OF VASOPRESSIN.

Authors:  W W DOUGLAS; A M POISNER
Journal:  J Physiol       Date:  1964-07       Impact factor: 5.182

3.  A new simple method which allows theoretical incorporation of radio-iodine into proteins and peptides without damage [proceedings].

Authors:  P Salacinski; J Hope; C McLean; V Clement-Jones; J Sykes; J Price; P J Lowry
Journal:  J Endocrinol       Date:  1979-05       Impact factor: 4.286

4.  Fluorometric assay of proteins in the nanogram range.

Authors:  P Böhlen; S Stein; W Dairman; S Udenfriend
Journal:  Arch Biochem Biophys       Date:  1973-03       Impact factor: 4.013

5.  Enhancement of depolarization-dependent neurosecretion from PC12 cells by forskolin-induced elevation of cyclic AMP.

Authors:  C S Rabe; J Schneider; R McGee
Journal:  J Cyclic Nucleotide Res       Date:  1982

Review 6.  Calcium messenger system: an integrated view.

Authors:  H Rasmussen; P Q Barrett
Journal:  Physiol Rev       Date:  1984-07       Impact factor: 37.312

7.  Phosphodiesterase activities for cyclic nucleotides in nerve endings from the bovine posterior pituitary gland.

Authors:  M R Vale; R V Baker; D B Hope
Journal:  J Neurochem       Date:  1984-02       Impact factor: 5.372

8.  Effects of diterpene forskolin on the release reaction and protein phosphorylation of human platelets.

Authors:  A González; E Aranda; D Mezzano; J Garrido
Journal:  Cell Biochem Funct       Date:  1983-10       Impact factor: 3.685

9.  Relaxant effects of forskolin in smooth muscle. Role of cyclic AMP.

Authors:  M J Muller; H P Baer
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1983-02       Impact factor: 3.000

10.  Forskolin and the release of noradrenaline in cerebrocortical slices.

Authors:  R Markstein; K Digges; N R Marshall; K Starke
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1984-01       Impact factor: 3.000

View more
  1 in total

1.  Modulation by fenoldopam (SKF 82526) and bromocriptine of the electrically evoked release of vasopressin from the rat neurohypophysis. Effects of dopamine depletion.

Authors:  K Racké; J Meuresch; B Trapp; E Muscholl
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1986-04       Impact factor: 3.000

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.